🏛️ Verified NIH Record • Updated 2026-04-15
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII) (NCT05763407)
🔵 Active, Not Recruiting Observational / Diagnostic ⚙️ Medical Device Protocol Sponsor: Foundry Innovation & Research 1, Limited (FIRE1)
🩺 Plain-English Summary (8th-Grade Level)
Early Feasibility Study of the NORM™ System in Heart Failure Patients
Who can join: Review the eligibility criteria below.
Location: University of Minnesota Medica Center — Minneapolis, Minnesota
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (8 Sites)
- University of Minnesota Medica Center — Minneapolis, Minnesota
- Columbia University Irving Medical Center/ New York Presbyterian Hospital — New York, New York
- Rochester General Hospital — Rochester, New York
- Duke University Medical Center — Durham, North Carolina
- Cleveland Clinic — Cleveland, Ohio
- The Ohio State University Wexner Medical Center — Columbus, Ohio
- Prisma Health — Greenville, South Carolina
- Austin Heart Central at the Heart Hospital of Austin — Austin, Texas
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Heart Failure
- REDUCE LAP-HFREF TRIAL — New York, New York
- Physiological Effects Ketone Ester in Heart — Cleveland, Ohio
- DASH Diet in Heart Failure Outpatients — Sacramento, California
- Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients — Huntsville, Alabama
- LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System. — Birmingham, Alabama
- A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation — Alexander City, Alabama
Explore by condition: All Heart Failure clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.